S.E. Usmani

488 total citations
9 papers, 352 citations indexed

About

S.E. Usmani is a scholar working on Rheumatology, Pharmacology and Molecular Biology. According to data from OpenAlex, S.E. Usmani has authored 9 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in S.E. Usmani's work include Osteoarthritis Treatment and Mechanisms (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Chemokine receptors and signaling (3 papers). S.E. Usmani is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Chemokine receptors and signaling (3 papers). S.E. Usmani collaborates with scholars based in Canada, South Korea and Germany. S.E. Usmani's co-authors include Frank Beier, C. Thomas Appleton, John S. Mort, M.A. Pest, Thomas Aigner, Suzanne M. Bernier, Vasek Pitelka, Gunwoo Kim, Ling Qin and Mamatha Bhat and has published in prestigious journals such as Endocrine Reviews, Scientific Reports and Bone.

In The Last Decade

S.E. Usmani

8 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.E. Usmani Canada 8 237 118 114 83 62 9 352
Nobuho Tanaka Japan 10 215 0.9× 49 0.4× 126 1.1× 78 0.9× 50 0.8× 15 371
L.A.B. Joosten Netherlands 9 190 0.8× 55 0.5× 105 0.9× 87 1.0× 24 0.4× 19 430
Stefan N. Andersen Netherlands 8 279 1.2× 76 0.6× 85 0.7× 51 0.6× 24 0.4× 10 421
S. Chubinskaya United States 6 273 1.2× 85 0.7× 122 1.1× 69 0.8× 71 1.1× 14 399
Miyuki Chijiiwa Japan 10 238 1.0× 74 0.6× 156 1.4× 92 1.1× 105 1.7× 13 486
M.H. van den Bosch Netherlands 9 240 1.0× 103 0.9× 212 1.9× 32 0.4× 24 0.4× 16 383
Youngnim Shin South Korea 8 225 0.9× 70 0.6× 140 1.2× 65 0.8× 16 0.3× 10 385
Changshan Geng Canada 9 452 1.9× 195 1.7× 176 1.5× 102 1.2× 48 0.8× 9 596
Hiroomi Tateishi Japan 9 155 0.7× 40 0.3× 89 0.8× 49 0.6× 43 0.7× 14 330
Tiezheng Sun China 9 118 0.5× 31 0.3× 118 1.0× 44 0.5× 56 0.9× 21 326

Countries citing papers authored by S.E. Usmani

Since Specialization
Citations

This map shows the geographic impact of S.E. Usmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.E. Usmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.E. Usmani more than expected).

Fields of papers citing papers by S.E. Usmani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.E. Usmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.E. Usmani. The network helps show where S.E. Usmani may publish in the future.

Co-authorship network of co-authors of S.E. Usmani

This figure shows the co-authorship network connecting the top 25 collaborators of S.E. Usmani. A scholar is included among the top collaborators of S.E. Usmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.E. Usmani. S.E. Usmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tran, Susan H, et al.. (2022). A Multimodal Intervention for Reducing Unnecessary Repeat Glycated Hemoglobin Testing. Canadian Journal of Diabetes. 47(1). 19–24.
2.
Bhat, Mamatha, S.E. Usmani, Amirhossein Azhie, & Minna Woo. (2020). Metabolic Consequences of Solid Organ Transplantation. Endocrine Reviews. 42(2). 171–197. 30 indexed citations
3.
Usmani, S.E., Veronica Ulici, M.A. Pest, et al.. (2016). Context-specific protection of TGFα null mice from osteoarthritis. Scientific Reports. 6(1). 30434–30434. 19 indexed citations
4.
Han, Mingzhi, Youn‐Kwan Jung, S.E. Usmani, et al.. (2015). CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation. Osteoarthritis and Cartilage. 23(6). 966–974. 25 indexed citations
5.
Appleton, C. Thomas, S.E. Usmani, M.A. Pest, et al.. (2015). Reduction in Disease Progression by Inhibition of Transforming Growth Factor α–CCL2 Signaling in Experimental Posttraumatic Osteoarthritis. Arthritis & Rheumatology. 67(10). 2691–2701. 58 indexed citations
7.
Usmani, S.E., C. Thomas Appleton, & Frank Beier. (2012). Transforming growth factor‐alpha induces endothelin receptor A expression in osteoarthritis. Journal of Orthopaedic Research®. 30(9). 1391–1397. 13 indexed citations
8.
Appleton, C. Thomas, S.E. Usmani, John S. Mort, & Frank Beier. (2009). Rho/ROCK and MEK/ERK activation by transforming growth factor-α induces articular cartilage degradation. Laboratory Investigation. 90(1). 20–30. 97 indexed citations
9.
Appleton, C. Thomas, S.E. Usmani, Suzanne M. Bernier, Thomas Aigner, & Frank Beier. (2007). Transforming growth factor α suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis. Arthritis & Rheumatism. 56(11). 3693–3705. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026